<DOC>
	<DOCNO>NCT02191475</DOCNO>
	<brief_summary>Selection tigecycline severe sepsis septic shock patient empirical antibiotic therapy ( Hai Zheng Energy Star ® ) combine piperacillin / tazobactam ( tazocin ® ) scheme , compare classical scheme , evaluate efficacy , safety index .</brief_summary>
	<brief_title>Effect Study Tigecycline Treat Severe Sepsis Septic Shock</brief_title>
	<detailed_description>Tigecycline representative glycylcycline antibiotic , wide antibacterial spectrum strong antibacterial activity , tigecycline almost gram positive bacteria gram negative bacteria atypical pathogen , anaerobic bacteria good antibacterial activity except Pseudomonas aeruginosa , Proteus . Safety organ function , patient renal insufficiency dialysis patient , dose adjustment require application tigecycline , mild moderate hepatic insufficiency patient need adjust dose tigecycline . Piperacillin / tazobactam also broad spectrum , potent antibiotic , especially strong bactericidal activity Pseudomonas aeruginosa , include resistant enzyme produce gram negative bacillus , accordance pharmacokinetic pharmacodynamic characteristic prolonged infusion time obtain strong bactericidal activity . These two potent drug broad antimicrobial spectrum , strong bactericidal activity , provide treatment severe sepsis septic shock new choice antibiotic selection , certain extent reduces resistance pressure , clinical safety .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<criteria>Be consistent severe sepsis septic shock diagnosis standard Age 18 year old , expect 5 day ICU APACHEⅡ score &gt; 15 By patient authorized person agree participate clinical trial sign informed consent Allergic penicillin , tigecycline allergic patient Patients abnormal liver function severe Be pregnant lactate woman Be sign informed consent patient Any expected increase patient risk factor interfere result clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>sepsis shock</keyword>
	<keyword>Tigecycline</keyword>
	<keyword>Piperacillin / tazobactam</keyword>
	<keyword>Abdominal infection</keyword>
</DOC>